We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical value of combined detection of serum APE1-Aabs and CEACAM-1 in the diagnosis of colorectal cancer.
- Authors
HUAJUN, W.; YING, F.; HONGXING, Z.; WEIFENG, S.; PINGYANG, S.; MINGDE, H.; GUOGUANG, L.
- Abstract
OBJECTIVE: To analyze the clinical value of combined detection of serum APE1-Aabs and CEACAM-1 in pathological diagnosis of colorectal cancer. PATIENTS AND METHODS: From December 2014 to July 2016, 60 patients with colorectal cancer and 50 healthy subjects were enrolled in this study. The levels of APE1-AAbs, CEACAM-1 and CEA in the serum were measured, and the clinical value of each index in the diagnosis of colorectal cancer was analyzed. RESULTS: The level of serum APE1-AAbs in colorectal cancer group was significantly higher than that in healthy control group (p < 0.05). The levels of serum CEACAM-1 and CEA in colorectal cancer patients were significantly higher than those in healthy control group (p < 0.05). The sensitivity and accuracy of APE1-AAbs and CEACAM-1 in the diagnosis of colorectal cancer were significantly higher than separate detection of APE1-AAbs, CEACAM-1 or CEA. CONCLUSIONS: Combined detection of serum APE1-AAbs and CEACAM-1 has the advantages of high sensitivity and good accuracy in the diagnosis of colorectal cancer, and it is worthy to be popularized in clinical practice.
- Subjects
COLON cancer; CANCER patients; EARLY detection of cancer; COLON cancer patients; COLON cancer treatment
- Publication
European Review for Medical & Pharmacological Sciences, 2018, Vol 22, Issue 5, p1286
- ISSN
1128-3602
- Publication type
Article